No child left behind: Startup snares $60M to target childhood cancers
May 21, 2020 at 17:44 PM EDT
The company's first drug was initially developed at South San Francisco's Sunesis Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|